We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PRCT icon
376
Procept Biorobotics
PRCT
$1.04B
$1.04B $18.28 0.54%
OLMA icon
377
Olema Pharmaceuticals
OLMA
$1.03B
$1.03B $11.76 4.26%
APMD
378
Apnimed, Inc. Common Stock
APMD
$1.02B
$1.02B $25.71 2.84%
REPL icon
379
Replimune Group
REPL
$1B
$1B $11.92 0.08%
AVTX icon
380
Avalo Therapeutics
AVTX
$980M
$980M $18.53 2.66%
EYPT icon
381
EyePoint Inc
EYPT
$978M
$978M $11.67 6.04%
OPK icon
382
Opko Health
OPK
$978M
$978M $1.31 0%
JANX icon
383
Janux Therapeutics
JANX
$973M
$973M $15.96 4.18%
ODTX
384
Odyssey Therapeutics
ODTX
$959M
$959M $19.96 10.1%
CSTL icon
385
Castle Biosciences
CSTL
$953M
$953M $31.18 2.6%
MRVI icon
386
Maravai LifeSciences
MRVI
$948M
$948M $6.43 0.16%
SANA icon
387
Sana Biotechnology
SANA
$946M
$946M $3.40 6.92%
OMER icon
388
Omeros
OMER
$937M
$937M $12.94 3.03%
AHCO icon
389
AdaptHealth
AHCO
$913M
$913M $6.71 38%
BVS icon
390
Bioventus
BVS
$909M
$909M $13.42 0.37%
GLAS
391
Glass House Brands
GLAS
$903M
$903M $10.07 0.1%
INMD icon
392
InMode
INMD
$883M
$883M $15.37 0.13%
AMPH icon
393
Amphastar Pharmaceuticals
AMPH
$877M
$877M $19.90 1.58%
TBPH icon
394
Theravance Biopharma
TBPH
$875M
$875M $16.88 0.06%
ANNX icon
395
Annexon
ANNX
$873M
$873M $5.33 1.52%
ABUS icon
396
Arbutus Biopharma
ABUS
$873M
$873M $4.42 1.38%
HSTM icon
397
HealthStream
HSTM
$871M
$871M $29.80 5.19%
TALK icon
398
Talkspace
TALK
$863M
$863M $5.15 1.15%
GERN icon
399
Geron
GERN
$860M
$860M $1.34 4.69%
SLDB icon
400
Solid Biosciences
SLDB
$849M
$849M $8.62 7.48%

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.